PubRank

Martin Petric

Author PubWeight™ 114.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The Genome sequence of the SARS-associated coronavirus. Science 2003 16.68
2 Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003 14.29
3 Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis 2004 4.29
4 Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med 2010 3.85
5 Novel avian influenza H7N3 strain outbreak, British Columbia. Emerg Infect Dis 2004 2.90
6 Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 2009 2.59
7 Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. BMJ 2011 2.50
8 GBV-C/hepatitis G virus infection and non-Hodgkin lymphoma: a case control study. Int J Cancer 2010 2.18
9 A 12-year prospective study of childhood herpes simplex encephalitis: is there a broader spectrum of disease? Pediatrics 2007 2.03
10 Comprehensive detection and serotyping of human adenoviruses by PCR and sequencing. J Clin Microbiol 2004 1.81
11 Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. J Infect Dis 2011 1.61
12 Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity. Science 2013 1.61
13 A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Clin Infect Dis 2012 1.58
14 Severe acute respiratory syndrome (SARS): a year in review. Annu Rev Med 2005 1.55
15 Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v). J Infect Dis 2012 1.47
16 Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, Canada. CMAJ 2007 1.43
17 Seasonal influenza vaccine and increased risk of pandemic A/H1N1‐related illness: first detection of the association in British Columbia, Canada. Clin Infect Dis 2010 1.43
18 Pediatric Epstein-Barr Virus-Associated Encephalitis: 10-Year Review. J Child Neurol 2006 1.41
19 The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. 1985. J Infect Dis 2004 1.40
20 Comparison of the incidence of influenza in relation to climate factors during 2000-2007 in five countries. J Med Virol 2010 1.36
21 The laboratory diagnosis of hepatitis B virus. Can J Infect Dis Med Microbiol 2005 1.29
22 SARS corona virus peptides recognized by antibodies in the sera of convalescent cases. Virology 2004 1.29
23 Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. J Infect Dis 2014 1.23
24 Multiplex PCR tests sentinel the appearance of pandemic influenza viruses including H1N1 swine influenza. J Clin Virol 2009 1.23
25 Detection of human influenza virus in the stool of children. Pediatr Infect Dis J 2006 1.19
26 Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic. CMAJ 2010 1.18
27 Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus. J Gen Virol 2006 1.16
28 Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants. J Infect Dis 2012 1.14
29 Randomized controlled trial of dose response to influenza vaccine in children aged 6 to 23 months. Pediatrics 2011 1.12
30 Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome. J Clin Microbiol 2002 1.10
31 Human illness and isolation of low-pathogenicity avian influenza virus of the H7N3 subtype in British Columbia, Canada. J Infect Dis 2006 1.10
32 Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J Clin Invest 2002 1.09
33 Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines. J Gen Virol 2008 1.07
34 The limitations of point of care testing for pandemic influenza: what clinicians and public health professionals need to know. Can J Public Health 2009 1.05
35 Coordinated response to SARS, Vancouver, Canada. Emerg Infect Dis 2006 1.04
36 Neonatal genital herpes simplex virus type 1 infection after Jewish ritual circumcision: modern medicine and religious tradition. Pediatrics 2004 1.03
37 Human papillomavirus 16 (HPV 16) and HPV 18 antibody responses measured by pseudovirus neutralization and competitive Luminex assays in a two- versus three-dose HPV vaccine trial. Clin Vaccine Immunol 2011 1.03
38 Influenza Β/Victoria antigen induces strong recall of Β/Yamagata but lower Β/Victoria response in children primed with two doses of Β/Yamagata. Pediatr Infect Dis J 2011 1.00
39 Pediatric Epstein-Barr virus-associated encephalitis: 10-year review. J Child Neurol 2006 0.99
40 A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice. Vaccine 2006 0.98
41 Using centralized laboratory data to monitor trends in herpes simplex virus type 1 and 2 infection in British Columbia and the changing etiology of genital herpes. Can J Public Health 2011 0.96
42 Fulminant disseminated Varicella Zoster virus infection without skin involvement. J Clin Virol 2002 0.95
43 An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus. Can J Infect Dis Med Microbiol 2006 0.95
44 The complete sequence of the bovine torovirus genome. Virus Res 2005 0.94
45 Risk factors for post-transplant lymphoproliferative disorder in pediatric patients: a case-control study. Pediatr Transplant 2005 0.93
46 Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: implications for a subunit vaccine. Vaccine 2006 0.92
47 Serum concentrations, efficacy, and safety of a new, intravenously administered varicella zoster immune globulin in pregnant women. J Clin Pharmacol 2002 0.91
48 Human torovirus: a new virus associated with neonatal necrotizing enterocolitis. Acta Paediatr 2005 0.91
49 Parvovirus B19 induced hepatic failure in an adult requiring liver transplantation. World J Gastroenterol 2009 0.88
50 H3N2v and other influenza epidemic risk based on age-specific estimates of sero-protection and contact network interactions. PLoS One 2013 0.86
51 Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines. Vaccine 2005 0.86
52 Gastrointestinal outbreaks associated with Norwalk virus in restaurants in Vancouver, British Columbia. Can Commun Dis Rep 2002 0.86
53 Detection of influenza H7N9 virus: all molecular tests are not equal. J Clin Microbiol 2013 0.86
54 Intracellular localization of the SARS coronavirus protein 9b: evidence of active export from the nucleus. Virus Res 2007 0.83
55 Molecular characterization of rotavirus strains from children in Toronto, Canada. J Clin Virol 2003 0.83
56 Prevalence of human papillomavirus 16 and 18 neutralizing antibodies in prenatal women in British Columbia. Clin Vaccine Immunol 2009 0.82
57 Detection of RNA in purified cytomegalovirus virions. Virus Res 2004 0.82
58 Age-specific frequencies of antibodies to Escherichia coli verocytotoxins (Shiga toxins) 1 and 2 among urban and rural populations in southern Ontario. J Infect Dis 2003 0.82
59 Mycoplasma pneumoniae pericarditis demonstrated by polymerase chain reaction and electron microscopy. Clin Infect Dis 2001 0.80
60 Epstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatment. Can J Infect Dis 2002 0.80
61 Herpes simplex virus in febrile neutropenic children undergoing chemotherapy for cancer: a prospective cohort study. Pediatr Infect Dis J 2007 0.80
62 The de-guanidinylated derivative of peramivir remains a potent inhibitor of influenza neuraminidase. Bioorg Med Chem Lett 2011 0.80
63 Amplification by long RT-PCR of near full-length norovirus genomes. J Virol Methods 2008 0.79
64 Transmission dynamics and risk factors for pandemic H1N1-related illness: outbreak investigation in a rural community of British Columbia, Canada. Influenza Other Respir Viruses 2012 0.78
65 Mumps virus detection during an outbreak in a highly unvaccinated population in British Columbia. Can J Public Health 2011 0.77
66 Optimization of a DNA vaccine against SARS. DNA Cell Biol 2007 0.77
67 Longitudinal analysis of genotype distribution of influenza A virus from 2003 to 2005. J Clin Microbiol 2006 0.77
68 Use of Lean response to improve pandemic influenza surge in public health laboratories. Emerg Infect Dis 2012 0.76
69 Case series of rash associated with influenza B in school children. Influenza Other Respir Viruses 2014 0.75
70 Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study. Can J Gastroenterol Hepatol 2014 0.75
71 Detection and species-level identification of primate herpesviruses with a comprehensive PCR test for human herpesviruses. J Clin Microbiol 2003 0.75
72 West Nile virus finally debuts in British Columbia 10 years after its introduction to North America. Vector Borne Zoonotic Dis 2010 0.75
73 Severe acute respiratory syndrome-associated coronavirus infection in Toronto children: a second look. Pediatrics 2009 0.75